sorafenib has been researched along with 2-fluoro-2-deoxyglucose-6-phosphate in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (2-fluoro-2-deoxyglucose-6-phosphate) | Trials (2-fluoro-2-deoxyglucose-6-phosphate) | Recent Studies (post-2010) (2-fluoro-2-deoxyglucose-6-phosphate) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 113 | 16 | 60 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ameye, L; Barbuto, AM; Ceyssens, S; Delaunoit, T; Deleporte, A; Demolin, G; El Mansy, H; Filleul, B; Flamen, P; Garcia, C; Guiot, T; Hendlisz, A; Holbrechts, S; Houbiers, G; Lhommel, R; Maréchal, R; Moreau, M; Paesmans, M; Peeters, M; Piccart, M; Van den Eynde, M; Van Laethem, JL | 1 |
1 trial(s) available for sorafenib and 2-fluoro-2-deoxyglucose-6-phosphate
| Article | Year |
|---|---|
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Disease-Free Survival; Female; Glucose-6-Phosphate; Humans; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Prospective Studies; Radiography; Sorafenib; Survival Rate | 2015 |